Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05583071
Title Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL (MTR2)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cologne
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.